Steven Widmer, MD
Orthopaedic Surgery · Wooster, OHNPI 1740418995
Payments from drug & device makers
What this record shows
The money is spread across several categories — travel and lodging (45.1%), food and beverage and education — rather than concentrated in one kind of arrangement. Stryker accounts for 68.0% of it on its own, with 11 other manufacturers making up the rest. Reporting peaked in 2019 at $3,371 and has fallen 63.4% since, to $1,234 in 2025.
Across 103 payments — averaging $78.20 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Stryker$5K
- Arthrex$1K
- Rock Medical Orthopedics, Inc.$872
- Baudax Bio Inc.$83
- Smith+Nephew$29
- Zimmer Biomet$27
- plus $109 from 6 others
What the payments were for
- Travel & lodging$3,63345%
- Food & beverage$3,22240%
- Education$1,20015%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Stryker | 85 | $5,479 |
| Arthrex | 5 | $1,456 |
| Rock Medical Orthopedics, Inc. | 3 | $872 |
| Baudax Bio Inc. | 1 | $83 |
| Smith+Nephew | 1 | $29 |
| Zimmer Biomet | 2 | $27 |
| Vertex | 1 | $25 |
| Medtronic | 1 | $23 |
| Next Science LLC | 1 | $23 |
| Medline Industries LP | 1 | $13 |
| Heron Therapeutics, Inc. | 1 | $13 |
| Acelrx Pharmaceuticals, Inc. | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$8,055 in reported general payments places this provider in the 65th percentile of 794 orthopaedic surgery providers in Ohio.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Meloxicam | 213 | $990 |
| Celecoxib | 29 | $664 |
| Methylprednisolone | 78 | $487 |
| Oxycodone Hcl | 59 | $265 |
| Amoxicillin | 333 | $240 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 32 | $173 |
| Mupirocin | 19 | $117 |
| Tramadol Hcl | 35 | $80 |
| Clindamycin Hcl | 65 | $74 |
| Montelukast Sodium | 12 | $52 |
Paid to pharmacies, not to this prescriber.
Other orthopaedic surgery in Wooster
- Reuben GobezieCleveland$12M
- Gregory BerletWorthington$9.6M
- Wael BarsoumCleveland$8.9M
- Brian CohenChillicothe$8.8M
- Joseph IannottiCleveland$7.1M
- John SontichYoungstown$3.6M
- Anthony MiniaciCleveland$3.1M
- David WelkerMiamisburg$2.8M
- Kenneth GreeneCleveland$2.6M
- Mark FroimsonCleveland$2.5M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.